Genetic engineering of T cells with receptors from NY-ESO-1-specific tumor-recognizing CD4+ T cell as a novel approach for adoptive T cell therapy

Podobne zapisy

• Non-classical antigen processing pathways are required for MHC class II-restricted direct tumor recognition by NY-ESO-1-specific CD4(+) T cells
  od: Matsuzaki, Junko, i wsp.
  Wydane: (2013)
• Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses
  od: Matsuzaki, Junko, i wsp.
  Wydane: (2015)
• Tumor-infiltrating NY-ESO-1–specific CD8(+) T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer
  od: Matsuzaki, Junko, i wsp.
  Wydane: (2010)
• Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer
  od: Odunsi, Kunle, i wsp.
  Wydane: (2007)
• NY-ESO-1 expression predicts an aggressive phenotype of ovarian cancer
  od: Szender, J. Brian, i wsp.
  Wydane: (2017)